Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications

Sangiliyandi Gurunathan1, Ah Reum Lee2, Jin Hoi Kim1

  • 1Department of Stem Cell and Regenerative Biotechnology, Konkuk University, Seoul 05029, Korea.

Insights

The COVID-19 pandemic saw a rise in deadly mucormycosis, or black fungus infections. This review explores how metal nanoparticles show promise in combating fungal growth, offering new avenues for treatment.

Area of Science:

  • Mycology
  • Nanotechnology
  • Infectious Diseases

Background:

  • The COVID-19 pandemic led to increased mucormycosis (black fungus) infections, a serious and often fatal secondary fungal disease.
  • Risk factors for mucormycosis include uncontrolled diabetes, immunosuppression, and extensive steroid use during COVID-19 treatment.
  • Existing antifungal agents have limitations, highlighting the urgent need for novel and effective antimicrobial strategies.

Purpose of the Study:

  • To review the impact of various metal nanoparticles on fungal growth, with a specific focus on mucormycosis.
  • To discuss the co-infection of black fungus in the context of the COVID-19 pandemic.
  • To elucidate the relationship between COVID-19 and mucormycosis.

Main Methods:

  • A comprehensive review of existing literature on metal nanoparticles and their antifungal properties.
  • Focus on nanoparticles containing silver, zinc oxide, gold, copper, titanium, magnetic, iron, and carbon.
  • Analysis of studies investigating the efficacy against various fungi, particularly Mucorales species.

Main Results:

  • Metal nanoparticles demonstrate potential as antimicrobial agents against fungal growth.
  • Specific nanoparticles show varying degrees of efficacy in inhibiting fungal proliferation.
  • The review highlights the need for further research into nanoparticle-based treatments for mucormycosis.

Conclusions:

  • Metal nanoparticles represent a promising area for developing new treatments against fungal infections like mucormycosis.
  • Understanding the interaction between COVID-19 and mucormycosis is crucial for effective patient management.
  • Further investigation into nanoparticle-based antifungals is warranted to combat rising fatalities.